Literature DB >> 8037728

A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen.

C Niyibizi1, R Chan, J J Wu, D Eyre.   

Abstract

Native type V collagen molecules resist mammalian collagenase but are cleaved by certain gelatinases. We report a prominent site of cleavage within the collagen type V molecules by 92 kDa gelatinase (MMP-9). The enzyme was purified from conditioned medium of a rabbit synovial cell line (HIG-82). It cleaved native type V collagen from bovine bone in solution at two molecular sites, one near the amino-terminus, the other producing a 3/5 C-terminal fragment. Amino-terminal sequence analysis of the individual alpha chains from this latter fragment showed that MMP-9 had cleaved between residues Gly439-Val in both alpha 1(V) and alpha (XI) and between residues Gly445-Leu in the alpha 2(V) chain. These sites are close to the previously reported trypsin-cleavage site. The findings imply that gelatinases may be necessary for initiating or completing degradation of type I/type V copolymeric fibrils for growth and remodeling of extracellular collagen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037728     DOI: 10.1006/bbrc.1994.1931

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  pH- and temperature-dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B.

Authors:  G F Fasciglione; S Marini; S D'Alessio; V Politi; M Coletta
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  Novel cyclopeptides for the design of MMP directed delivery devices: a novel smart delivery paradigm.

Authors:  El-Farouck Moustoifa; Mohamed-Anis Alouini; Arnaud Salaün; Thomas Berthelot; Aghleb Bartegi; Sandra Albenque-Rubio; Gérard Déléris
Journal:  Pharm Res       Date:  2010-05-08       Impact factor: 4.200

3.  Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.

Authors:  A De Paepe; L Nuytinck; I Hausser; I Anton-Lamprecht; J M Naeyaert
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

Review 4.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

5.  A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.

Authors:  V Tiriveedhi; N Angaswamy; D Brand; J Weber; A G Gelman; R Hachem; E P Trulock; B Meyers; G Patterson; T Mohanakumar
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

6.  Directed evolution of protease beacons that enable sensitive detection of endogenous MT1-MMP activity in tumor cell lines.

Authors:  Abeer Jabaiah; Patrick S Daugherty
Journal:  Chem Biol       Date:  2011-03-25

7.  Fluorescence-Shadowing Nanoparticle Clusters for Real-Time Monitoring of Tumor Progression.

Authors:  Oanh-Vu Pham-Nguyen; JiUn Shin; Yeonju Park; Sila Jin; Song Rae Kim; Young Mee Jung; Hyuk Sang Yoo
Journal:  Biomacromolecules       Date:  2022-04-22       Impact factor: 6.978

8.  Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9.

Authors:  Susan MacLauchlan; Eleni A Skokos; Norman Meznarich; Dana H Zhu; Sana Raoof; J Michael Shipley; Robert M Senior; Paul Bornstein; Themis R Kyriakides
Journal:  J Leukoc Biol       Date:  2009-01-13       Impact factor: 4.962

9.  MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity.

Authors:  Rajagopalan Bhaskaran; Mark O Palmier; Janelle L Lauer-Fields; Gregg B Fields; Steven R Van Doren
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

Review 10.  Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.

Authors:  Gregg B Fields
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.